Neal Muni - Oct 14, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role: EVP & COO
Signature: /s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol: CMRA
Transactions as of: Oct 14, 2023
Transactions value $: $0
Form type: 4
Date filed: 10/16/2023, 05:02 PM
Previous filing: Feb 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRA	Stock Option (Right to Purchase)	Award	$0	+60K		$0.00	60K	Oct 14, 2023	Common Stock	60K	$0.29	Direct	F1

Neal Muni is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	On October 4, 2023, the reporting person was granted an option to purchase 60,000 shares of common stock of the issuer. The option vested in full following the satisfaction of certain performance criteria including the execution of a separation agreement and release by the reporting person and the expiration of a seven-day revocation period without the reporting person revoking the separation agreement and release.

Content

On October 4, 2023, the reporting person was granted an option to purchase 60,000 shares of common stock of the issuer. The option vested in full following the satisfaction of certain performance criteria including the execution of a separation agreement and release by the reporting person and the expiration of a seven-day revocation period without the reporting person revoking the separation agreement and release.